Your Work, Our Purpose
Your work powers discovery, advances patient care, and shapes the future of science. Whether you’re exploring complex biology or ensuring accuracy in diagnostics, we understand how much it matters. That’s why our instruments, reagents, quality control solutions, and data tools are built around your needs. We know how important your work is, because it’s our work, too.
Popular Product Categories
High Sensitivity and Precision for NSCLC Mutation Detection
Detect key EGFR, KRAS, and BRAF mutations in liquid biopsy or FFPE samples with ≤0.1% VAF sensitivity—all in under 8 hours. Built on our trusted ddPCR™ Technology, this kit delivers the sensitivity and precision your oncology lab demands.
Specialty Immunoassay Plus Controls
Test 14 specialty immunoassay analytes with one control. Now with PCT and improved shelf stability, Specialty Immunoassay Plus Controls ensure consistent, reliable patient results in every run.
Latest from Bio-Rad
Recent News, Events and Webinars
- Image
Process SeparationsBPI Europe 2026Discover solutions for advancing downstream purification of complex biologics. Explore innovative strategies, gain practical insights to support method and process development, and connect with our purification experts to optimize your workflows.
2026-04-27Vienna Austria - https://discover.pharmaignite.com/smarter-molecular-strategies?utm_source=lp&utm_medium=client&utm_campaign=promo?WT.mc_id=260324051211Image
Life Science ResearchAdvancing Infectious Disease Studies With Integrated Molecular WorkflowsLearn how hVIVO uses ddPCR™ technology, NGS, and RNA-seq to accelerate infectious disease research through precise pathogen detection and host-response analysis.
2026-04-29 - https://us02web.zoom.us/webinar/register/WN_rpVbsVVrRmaj4mXls57Fwg#/registrationImage
Life Science ResearchctDNA-Guided Risk Stratification and Surveillance in Colorectal CancerJoin Tenna Vesterman Henriksen, PhD, Assistant Professor at Aarhus University Hospital, to learn how tumor‑informed ctDNA analysis using ddPCR™ refines recurrence risk assessment and enables earlier, more precise surveillance in colorectal cancer.
2026-04-30
